IN-STENT RESTENOSIS (ISR): THE PROBLEM AND POSSIBLE SOLUTIONS

Authors

  • AFSAR RAZA
  • AZMAT HAYAT

DOI:

https://doi.org/10.47144/phj.v36i1-4.81

Keywords:

THE PROBLEM AND POSSIBLE SOLUTIONS

Abstract

This review article is focused on instent restenosis (ISR); its pathogenesis and different modalities tried for
the treatment of this challenging problem. The dream of an effective treatment for ISR has eluded decades of
effort by an army of investigators. No matter how much skill, experience, time, and effort the interventionist
brings to the table, ISR can entirely reverse a perfect procedural result within months. Until now many
strategies like conventional balloon angioplasty, perfusion balloon angioplasty (prolonged inflation),
debulking of the lesion prior to balloon angioplasty using rotational or directional atherectomy, stent within
stent implantation and treatment with Laser have all been tried but non has proved to be a fully effective
solution to the problem or non has proved to be significantly superior to the other. However the efficacy
provided by vascular brachytherapy and antiproliferative effect of the drug eluting stents has offered a hope
to patients with in-stent restenosis

Downloads

Download data is not yet available.

Downloads

How to Cite

1.
RAZA A, HAYAT A. IN-STENT RESTENOSIS (ISR): THE PROBLEM AND POSSIBLE SOLUTIONS. Pak Heart J [Internet]. 2012May12 [cited 2024Nov.23];36(1-4). Available from: https://pakheartjournal.com/index.php/pk/article/view/81

Issue

Vol. 36 No. 1-4 (2003): Pakistan Heart Journal

Section

Original Article

License

When an article is accepted for publication in the print format, the author will be required to transfer exclusive copyright to the PHJ and retain the rights to use and share their published article with others. However, re-submission of the full article or any part for publication by a third party would require prior permission of the PHJ.

Online publication will allow the author to retain the copyright and share the article under the agreement described in the licensing rights with creative commons, with appropriate attribution to PHJ. Creative Commons attribution license CC BY 4.0 is applied to articles published in PHJ https://creativecommons.org/licenses/by/4.0/